GENE ONLINE|News &
Opinion
Blog

2026-04-01|

Dr. Amy Shirong Lu Appointed Editor-in-Chief of JMIR Serious Games

by GOAI
Share To

JMIR Publications has announced the appointment of Dr. Amy Shirong Lu as the new Editor-in-Chief of *JMIR Serious Games*. The decision marks a significant development in the field of digital health research, with Dr. Lu set to lead the journal’s efforts in advancing studies at the intersection of serious gaming technology and health science. Her leadership is expected to play a key role in broadening the journal’s scope and influence within this specialized area.

Dr. Lu brings extensive expertise to her new position, having established herself as a prominent figure in serious games research and their applications in healthcare. *JMIR Serious Games* focuses on publishing peer-reviewed studies that explore how gaming technologies can be utilized for education, behavior change, rehabilitation, and other health-related purposes. With Dr. Lu at the helm, the journal aims to further its mission of providing high-quality research that bridges technology and health sciences while fostering innovation in this rapidly evolving field.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 1, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top